Tenax Therapeutics, Inc. (TENX)
1.98
+0.05
(+2.59%)
USD |
NASDAQ |
Oct 02, 16:00
1.97
-0.01
(-0.51%)
Pre-Market: 20:00
Tenax Therapeutics Price to Book Value : 0.5569 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.5569 |
| October 01, 2026 | 0.5429 |
| September 30, 2026 | 0.5316 |
| September 29, 2026 | 0.5175 |
| September 28, 2026 | 0.5204 |
| September 25, 2026 | 0.5091 |
| September 24, 2026 | 0.5316 |
| September 23, 2026 | 0.5344 |
| September 22, 2026 | 0.5457 |
| September 21, 2026 | 0.5288 |
| September 18, 2026 | 0.5344 |
| September 17, 2026 | 0.5232 |
| September 16, 2026 | 0.5119 |
| September 15, 2026 | 0.5147 |
| September 14, 2026 | 0.5232 |
| September 11, 2026 | 0.5232 |
| September 10, 2026 | 0.5485 |
| September 09, 2026 | 0.5991 |
| September 08, 2026 | 0.5569 |
| September 04, 2026 | 0.5457 |
| September 03, 2026 | 0.5007 |
| September 02, 2026 | 0.5204 |
| September 01, 2026 | 0.5063 |
| August 31, 2026 | 0.5175 |
| August 28, 2026 | 0.5991 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.616 |
| August 26, 2026 | 0.5963 |
| August 25, 2026 | 0.6526 |
| August 24, 2026 | 0.5204 |
| August 21, 2026 | 0.4922 |
| August 20, 2026 | 0.5007 |
| August 19, 2026 | 0.5344 |
| August 18, 2026 | 0.4782 |
| August 17, 2026 | 0.481 |
| August 14, 2026 | 0.5063 |
| August 13, 2026 | 0.5147 |
| August 12, 2026 | 0.4838 |
| August 11, 2026 | 0.4557 |
| August 10, 2026 | 0.3868 |
| August 07, 2026 | 3.780 |
| August 06, 2026 | 3.744 |
| August 05, 2026 | 3.671 |
| August 04, 2026 | 3.887 |
| August 03, 2026 | 4.031 |
| July 31, 2026 | 3.853 |
| July 30, 2026 | 4.247 |
| July 29, 2026 | 4.168 |
| July 28, 2026 | 4.444 |
| July 27, 2026 | 4.554 |
| July 24, 2026 | 4.087 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Exicure, Inc. | 7.502 |
| Century Therapeutics, Inc. | 1.189 |
| Absci Corp. | 7.716 |
| Celularity, Inc. | -- |
| Cardio Diagnostics Holdings, Inc. | 0.7811 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0225 |
| Price | 1.98 |
| Earnings Yield | -74.49% |
| Market Cap | 63.26M |
| PEGY Ratio | -0.0225 |